An American infectious diseases expert announced that an experiment run by the GlaxoSmithKline pharmaceutical company, involving an Ebola vaccine, has not shown any unusual side effects thus far.
The experiment took place on the 2nd of September. Ten healthy people took part. Ten more healthy volunteers will receive the vaccine in the next few days.